? Administrative Core The Administrative Core will provide the leadership to ensure that this Center continually stimulates new, significant and innovative research while providing new cutting edge technical methodologies to enhance the goals of drug abuse research projects funded to investigators at this and collaborating institutions. The Center Director will assume responsibility for all aspects of this center, but will be provided frequent input from the internal advisory committee, a group of highly accomplished NIDA-funded drug abuse scientists who have worked cooperatively together for years, and from the external advisory committee, a group of well-known drug abuse researchers in other institutions across the country. In addition the individual Core Leads and Co- Investigators will serve in an advisory capacity with the major goal being to stimulate new innovative research available through collaboration among the cores. The Administrative Core will rely heavily on interaction and communication among all scholars and advisors as they have successfully done for years. There has been a long history of collaboration among the drug abuse researchers at this and collaborating institutions and this experience will provide the essence for the leadership of this center, as reflected in the progress report of this renewal proposal. The Administrative Core's personnel will continue to assume the lead in scheduling and organizing annual research retreats and monthly research discussion groups that include Center leaders, faculty, postdoctoral fellows, and graduate students. The administrative support for this center will be provided by the staff of the chair's and finance offices of the Department of Pharmacology and Toxicology at VCU. Staff members have decades of experience carrying out these functions for federally funded research grants and centers, training grants, contracts, fellowships, etc., all while handling the administration of all other aspects of a large and very productive academic department. They have provided this support exceptionally well during the first funding cycle of this center. Commitments are in place from the Deans of the Schools of Medicine and Pharmacy, as well as from the Vice President for Research and Innovation, to continue to provide financial and other support for the pilot projects core of this center (please see letters included in the Pilot Projects program core).

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
2P30DA033934-06
Application #
9572669
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
2024-03-31
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Donvito, Giulia; Nass, Sara R; Wilkerson, Jenny L et al. (2018) The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain. Neuropsychopharmacology 43:52-79
Wolstenholme, Jennifer T; Bowers, M Scott; Pais, Alexander B et al. (2018) Dietary Omega-3 Fatty Acids Differentially Impact Acute Ethanol-Responsive Behaviors and Ethanol Consumption in DBA/2J Versus C57BL/6J Mice. Alcohol Clin Exp Res :
Hermes, Douglas J; Xu, Changqing; Poklis, Justin L et al. (2018) Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS. Neuropharmacology 141:55-65
Mischel, Ryan A; Dewey, William L; Akbarali, Hamid I (2018) Tolerance to Morphine-Induced Inhibition of TTX-R Sodium Channels in Dorsal Root Ganglia Neurons Is Modulated by Gut-Derived Mediators. iScience 2:193-209
Shin, Myungsun; Snyder, Helena W; Donvito, Giulia et al. (2018) Liposomal Delivery of Diacylglycerol Lipase-Beta Inhibitors to Macrophages Dramatically Enhances Selectivity and Efficacy in Vivo. Mol Pharm 15:721-728
Gonek, Maciej; McLane, Virginia D; Stevens, David L et al. (2018) CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward. Brain Behav Immun 69:124-138
Curry, Zachary A; Wilkerson, Jenny L; Bagdas, Deniz et al. (2018) Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy. J Pharmacol Exp Ther 366:169-183
Cooper, Ziva D; Poklis, Justin L; Liu, Fei (2018) Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073. Neuropharmacology 134:92-100
Akbarali, Hamid I; Dewey, William L (2017) The gut-brain interaction in opioid tolerance. Curr Opin Pharmacol 37:126-130
Dempsey, Sara K; Poklis, Justin L; Sweat, Kacie et al. (2017) Acute Toxicity From Intravenous Use of the Tricyclic Antidepressant Tianeptine. J Anal Toxicol 41:547-550

Showing the most recent 10 out of 93 publications